IN THE HIGH COURT OF DELHI AT NEW DELHI
C. Hari Shankar, J.
Dr. Reddys Laboratories Limited – Appellant
Versus
Fast Cure Pharma – Respondent
CS(COMM) 436 of 2021
Decided On : 16-08-2023
Trademark Infringement - Pharmaceutical Products - The plaintiff alleges infringement, by the defendant, of the plaintiff's trademark RAZO by use of the mark RAZOFAST. The court found that the defendant's use of RAZOFAST was deceptively similar to the plaintiff's mark and constituted infringement and passing off. The court decreed the suit in favor of the plaintiff and granted permanent injunction and costs.
Fact of the Case:
The plaintiff alleged that the defendant infringed its trademark RAZO by using the mark RAZOFAST for identical pharmaceutical products. The plaintiff sought permanent injunction, disclosure of information, delivery of offending material, damages, rendition of accounts, and costs.
Finding of the Court:
The court found that the defendant's use of RAZOFAST was deceptively similar to the plaintiff's mark, and the trade dress of the defendant was also similar to that of the plaintiff. The court held that the defendant's actions constituted infringement and passing off, and decreed the suit in favor of the plaintiff.
Issues: Trademark infringement, passing off, permanent injunction, damages, rendition of accounts, costs.
Ratio Decidendi: The defendant's use of RAZOFAST was deceptively similar to the plaintiff's mark, indicating an intent to ride on the goodwill and reputation of the plaintiff. The court found a clear case of infringement and passing off in favor of the plaintiff.
Final Decision: The suit was decreed in favor of the plaintiff, granting permanent injunction, costs, and other reliefs sought.
JUDGMENT (Oral)
CS(COMM) 436/2021
1. The plaintiff alleges infringement, by the defendant, of the plaintiff's trademark, RAZO, by use of the mark RAZOFAST, for identical pharmaceutical products.
2. The active ingredient of the product of the plaintiff and the defendant is the same, i.e. Rabeprazole.
3. The plaintiff holds the following registrations:
| S.No. | Trademark | Reg. No. | Reg. Date | Class |
| 1. | [IMG] | 1320974 | 18/11/2004 | 5 |
| 2. | RAZO | 2336815 | 24/05/2012 | 5 |
| 3. | RAZO | 2370917 | 27/07/2012 | 5 |
These registrations are stated to be valid and subsisting as on date.
4. The following photographs of the packs in which the plaintiff markets its products have also been provided in the documents filed with the plaint:
[IMG]
5. The plaint alleges that, towards the second week of August, 2021, the plaintiff came to know that the defendant was manufacturing, marketing and selling rabeprazole tablets, under the mark RAZOFAST.
6. This, alleges the plaint, was a transparent attempt at capitalising on the plaintiff's goodwill and creating an association between the product of the defendant and the mark of the plaintiff, with the suffix "FAST" added to the name to make it appear that the product would provide faster relief. It is alleged that the overall trade dress adopted by the defendant in respect of its product is also such as would enhance the possibility of confusion between the marks of the defendant and the plaintiff. Photographs of the defendant's packs are also provided with the plaint, and may be reproduced thus:
[IMG]
7. The impugned mark, RAZOFAST, stands registered in favour of the defendant on 25 June, 2018. The defendant claims user since 6 February, 2017, whereas the plaintiff claims user since 2002.
8. Predicated on these facts, the plaintiff has instituted the present suit against the defendant, praying thus:
"It is, therefore, prayed that this Hon'ble Court may be pleased to grant the following reliefs:
i. An order for permanent injunction restraining the Defendant, its partners, officers, servants, employees, dealers, agents, representatives, stockiest, distributors and all other persons acting on behalf the Defendant from manufacturing, marketing, supplying, selling and offering for sale including online sale, advertising, directly or indirectly medicinal and pharmaceutical preparations under the trademark RAZOFAST and/or any other mark identical or deceptively similar to the Plaintiff's mark RAZO and/or in any other manner whatsoever as may be likely to cause confusion or deception amounting to infringement of the Plaintiff's trade mark registrations as mentioned in paragraph No. 9 of the plaint;
ii. An order for permanent injunction restraining the Defendant, its partners, officers, servants, employees, dealers, agents, representatives, stockiest, distributors and all other persons acting on behalf the Defendant from manufacturing, marketing, supplying, selling and offering for sale including online sale, advertising, directly or indirectly medicinal and pharmaceutical preparations under the trademark RAZOFAST and/or any other mark identical or deceptively similar to the Plaintiff's mark RAZO and/or in any manner whatsoever as may be likely to cause confusion or deception amounting to passing off its goods and business as and for those of the Plaintiff;
iii. For disclosure of information by Defendant about sale of the total products under the impugned mark RAZOFAST and provide the last batch number of product manufactured under the mark RAZOFAST with details of payments received;
iv. For delivery upon affidavit by the Defendant to the Plaintiff all the offending material, goods, cartons, labels, dies, wrapping and other material bearing the offending trade marks for purposes of destruction and/or obliteration as the case may be;
v. An order directing the Defendant to remove all listings of the impugned mark RAZOFAST from its websites, B2B websites or any other online directories, B2B, B2C website or portals that may be used by the Defendant to promote the
Deceptive similarity of trademarks and trade dress can constitute trademark infringement and passing off.
The central legal point established is the application of Section 11(1)(b) of the Trade Marks Act, which disentitles the registration of a mark if it is deceptively similar to an existing registered ....
The judgment establishes the principle that phonetic similarity between trademarks can constitute infringement, and lack of a credible defense can lead to summary judgment in trademark cases.
Registered trademark holders have exclusive rights and can seek injunction against unauthorized use that causes consumer confusion, with presumption of confusion if the trademarks are identical.
The use of the impugned marks EYESITE/Fig.2 and KL (Label) by the Defendants is likely to cause confusion and deception, thereby constituting infringement of the Plaintiffs' registered trademarks und....
The court emphasized likelihood of consumer confusion in trademark law, holding that similar marks can infringe established trademarks regardless of differences in service or field, thus supporting t....
The main legal point established in the judgment is the requirement for specific evidence and proof of unlawful gain to validate a claim for damages in a trademark infringement case.
Section 124 of the Trade Marks Act, 1999, when rectification proceedings are pending, the suit has to be stayed, pending final disposal of such proceedings.
The court ruled on trademark infringement, emphasizing phonetic and visual similarity between ISITE and EYESITE, resulting in consumer confusion, leading to a permanent injunction against the infring....
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.